Revenue (Quarterly) Chart

View Revenue (Quarterly) for UNVC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.021M
March 31, 2026 0.0192M
December 31, 2025 0.0175M
September 30, 2025 0.0334M
June 30, 2025 0.0179M
March 31, 2025 0.0162M
December 31, 2024 0.0142M
September 30, 2024 0.0054M
June 30, 2024 0.0066M
March 31, 2024 0.0106M
December 31, 2023 0.0049M
September 30, 2023 0.0043M
June 30, 2023 0.007M
March 31, 2023 0.0048M
December 31, 2022 0.0047M
September 30, 2022 0.0135M
June 30, 2022 0.0135M
March 31, 2022 0.0088M
December 31, 2021 0.0113M
September 30, 2021 0.0081M
June 30, 2021 0.0282M
March 31, 2021 0.006M
September 30, 2010 0.001M
September 30, 2007 0.0084M
June 30, 2007 0.0144M
Date Value
March 31, 2007 0.0008M
December 31, 2006 0.005M
September 30, 2006 0.0028M
June 30, 2006 0.0065M
March 31, 2006 0.0072M
December 31, 2005 0.003M
September 30, 2005 1.445M
June 30, 2005 0.0451M
March 31, 2005 0.04M
December 31, 2004 0.0317M
September 30, 2004 4.742M
June 30, 2004 4.513M
March 31, 2004 4.208M
December 31, 2003 5.49M
September 30, 2003 4.064M
June 30, 2003 4.328M
March 31, 2003 2.252M
December 31, 2002 0.6614M
September 30, 2002 0.7021M
June 30, 2002 0.863M
March 31, 2002 0.651M
December 31, 2001 1.09M
September 30, 2001 0.714M
June 30, 2001 0.7563M
March 31, 2001 1.346M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 12.59B
Align Technology, Inc. 1.056B
AngioDynamics, Inc. 86.61M
Accuray, Inc. 100.92M
Alphatec Holdings, Inc. 213.51M